The percentage of teachers who are using artificial intelligence-driven tools in their classrooms nearly doubled between 2023 and 2025, according to data from the EdWeek Research Center. In 2023, a ...

A cache of newly released photos taken inside Jeffrey Epstein’s Manhattan den of depravity shows a horde of bizarre role-play costumes and disturbing artworks of children in compromising positions.

Facepalm: Users have long criticized Windows 11 File Explorer as inferior to its Windows 10 predecessor. The essential tool suffers from slow launches, sluggish file searches, and delayed right-click ...

Google was accused in a lawsuit of using its Gemini AI assistant to unlawfully track the private communications of users of its Gmail, instant messaging and videoconference programs. In the past, ...

The IRS has notified states that offered the free, government tax filing service known as Direct File in 2025 that the program won’t be available next filing season. In an email sent from the IRS to ...

College students are being wrongly accused of using AI to cheat on their assignments by their university — based, in a headache-inducing twist, on the findings of another AI system. A student named ...

An Adelphi University student is suing the school after it accused him of using artificial intelligence to write an essay deemed “too advanced” for a first-year student — a charge he calls “completely ...

The last time I wrote about IDEAYA Biosciences (IDYA), it was with respect to a Seeking Alpha article entitled "Ideaya Biosciences: Value Beyond Darovasertib With ADC Program IDE849." With respect to ...

The House Committee on Oversight and Government Reform has released more than 30,000 pages of documents connected to the Jeffrey Epstein investigations after an August subpoena, and bipartisan ...

An AT&T logo is seen on Aug. 17, 2025. An AT&T logo is seen on Aug. 17, 2025.Jonathan Raa—Getty Images. Reporter AT&T customers in the United States could be entitled to up to $7,500 after the ...

Corvus Pharmaceuticals (CRVS) is in the process of evaluating the use of its interleukin-2-inducible T cell kinase [ITK] inhibitor for the treatment of patients with a wide variety of lymphoma types, ...